Skip to content. | Skip to navigation

Garvan Institute

Sections
 

Laybutt

 

Interestingly, the majority of overweight individuals do not develop type 2 diabetes because their pancreatic  beta cells compensate with enhanced insulin secretion. It is the failure of beta cells compensation that is fundamental to the development of diabetes. The beta cell is a highly specialised cell with a unique metabolic profile and differentiation specifically geared towards making these cells able to sense fluctuations in circulating glucose levels and secrete insulin accordingly.

We propose that in susceptible individuals, a gradual rise in blood glucose (hyperglycaemia) and lipid levels resulting from increasing obesity and insulin resistance leads to a loss of the unique gene expression pattern that is necessary for appropriate insulin secretion. This exacerbates hyperglycaemia, which causes beta cell dedifferentiation and eventually the death of beta cells by apoptosis. Our group has recently found evidence in several models of diabetes that supports this hypothesis. We have identified and are investigating novel candidate genes that potentially link hyperglycaemia to the development of impaired beta cell function. Furthermore, we are investigating endoplasmic reticulum (ER) stress as an exciting potential mechanism for beta cell destruction in type 1 and type 2 diabetes.


Staff


Mia AkerfeldtResearch Assistant
 Mia Åkerfeldt
Visiting Student
Jennifer Howes


See also:

Biden Research Group

Schmitz-Peiffer Research Group


News

 

Potential to prevent loss of insulin in Type 2 diabetes

MEDIA RELEASE: 14 Jul 2008
Until now, it was thought that the processes leading to the death of insulin-secreting pancreatic cells were similar in both types of diabetes. Scientists at Garvan have now shown that the process is quite different in the two diseases. They have also identified a promising therapeutic target for people with Type 2 diabetes
 
 

Personal tools